Walgreens Boots Alliance Sees $0.20 Loss Per Share in Q3 2025
Deerfield, Thursday, 26 June 2025.
Walgreens Boots Alliance reported a $0.20 loss per share in Q3 2025 compared to a $0.40 profit last year, due to significant financial and market challenges.
Financial Performance Overview
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported a net loss per share of $0.20 for the third quarter of fiscal year 2025, compared to earnings of $0.40 per share in the same quarter of the previous year. This decline is primarily attributed to the absence of after-tax gains from fair value adjustments on variable prepaid forward derivatives that were recorded in the previous year [1][2].
Revenue Growth and Segment Performance
Despite the earnings decline, Walgreens reported a 7.2% increase in sales year-over-year, reaching $39.0 billion. On a constant currency basis, sales increased by 6.9%. The U.S. Retail Pharmacy segment contributed significantly to this growth with sales surging by 7.8% year-over-year [1][3].
Challenges in U.S. Healthcare Segment
In contrast to the robust sales in retail pharmacy, the U.S. Healthcare segment experienced a decline in sales, with revenue slightly down to $2.1 billion. This was attributed to lower risk-based and fee-for-service revenue at VillageMD [4].
Strategic Focus Amidst Acquisition News
Amid ongoing performance challenges, Walgreens Boots Alliance has announced its acquisition by entities affiliated with Sycamore Partners. Consequently, the company has withdrawn its fiscal 2025 guidance, indicating a strategic realignment in anticipation of the merger’s closure expected in the third or fourth quarter of 2025 [1][3][5].
Sources
- investor.walgreensbootsalliance.com
- news.alphastreet.com
- site.financialmodelingprep.com
- www.streetinsider.com
- www.alphastreet.com